Nano Drug Delivery Systems for Colon Cancer
Innovations, Challenges, and Applications
- 1st Edition - June 1, 2026
- Latest edition
- Editors: Arun Kumar Singh, Vipan Kumar, Pranav Kumar Prabhakar, Meenakshi Dhanawat, Neeraj Mishra
- Language: English
Nano Drug Delivery Systems for Colon Cancer: Innovations, Challenges, and Applications is a breakthrough exploration that delves into the latest advancements in colon cancer diagno… Read more
It serves as a vital resource, fostering interdisciplinary knowledge and advancements that have the potential to revolutionize colon cancer therapeutics. The book's interdisciplinary approach ensures it is a beacon of knowledge for those seeking to navigate and innovate within this critical field.
- Delivers an in-depth exploration of the design, synthesis, and application of nanodrug delivery systems
- Unveils groundbreaking and state-of-the-art approaches in colon cancer diagnosis and treatment, placing readers at the cutting edge of medical innovation
- Showcases how strategic design methodologies can dramatically boost therapeutic efficacy, paving the way for more effective colon cancer treatments
2. Current trends of targeted nanoparticulate carriers for the treatment of colon cancer
3. Lipid nanocarrier-based drug delivery for the treatment of colon cancer
4. Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
5. siRNA polymer conjugates for the delivery of RNAi therapeutics for the treatment of Colon Cancer
6. Carbon-Based Quantum Dots and Nanotubes for Colon Cancer Targeting and Drug Delivery
7. Recent trends of extracellular vesicles for therapeutic intervention of Colon Cancer
8. Mitochondria-targeted drug delivery systems for the effective treatment of colon cancer
9. Revolutionizing Colon Cancer Care: Advances in Carbon-Based Materials as theranostic agents
10. Surface modified Metal Nanoparticles in Colon Cancer Therapy
11. Nano-based Phyto drug delivery systems for the management of colon cancer
12. Role of polymeric nanoparticles for the treatment of Colon cancer
13. Nanomicelles based drug delivery systems as for targeted therapy of colon cancer
14. Regulatory framework in the Nanomedicine targeting Colon Cancer
15. Current and future perspectives of nanomedicine in colon cancer treatment
- Edition: 1
- Latest edition
- Published: June 1, 2026
- Language: English
AS
Arun Kumar Singh
VK
Vipan Kumar
Vipan Kumar is working as a Professor (Associate) at Department of Pharmaceutical Chemistry, JCDM College of Pharmacy, Sirsa. Dr. Kumar has more than 10 years of teaching and research experience. He has published dozens of publications in peer-reviewed international and national journal. He has authored 2 books. Dr. Kumar is an editorial and reviewer board member of several scientific journals of intentional repute. He is also serving as a CPCSEA Nominee in various institutes’ IAEC committees and served in University PGBOS committees.
PP
Pranav Kumar Prabhakar
MD
Meenakshi Dhanawat
Dr. Meenakshi Dhanawat is an Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, with over 18 years of experience in pharmaceutical sciences. She holds a Master’s degree from NIPER Mohali and a PhD from IIT-BHU Varanasi, specializing in medicinal chemistry and CNS drug delivery targeting 5HT1A/2A receptors. Dr. Dhanawat’s research spans targeted therapies like JAK-STAT inhibitors, signaling pathways in health and disease, synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, and herbal drug extraction. She has published 75 research articles and reviews, holds 5 patents, authored 6 books, contributed 13 book chapters, and edited 5 books. An active participant in national and international conferences, she has received prestigious grants from AAPS, DBT, and DST, along with the Rajiv Gandhi National Fellowship. Dr. Dhanawat’s work significantly advances pharmaceutical innovation and education, reflecting her commitment to scientific excellence and mentorship.
NM